Noom Med semaglutide: price, structure, and position (2026)

Noom Med↗ charges $199 a month all-in for compounded semaglutide at the 2.4 mg maintenance basis — dose-flat across the entire ladder, with no membership fee — ranking #12 of 20 verified programs (captured 2026-08-08).

Updated 2026-08-10 · figures captured 2026-08-09 · how we verify

SOURCE-VERIFIED · captured 2026-08-08 · source · archive

§ The semaglutide record, in words

What Noom Med bills for semaglutide, exactly

Noom Med’s semaglutide program bills $199 a month once every mandatory fee is counted, measured at the 2.4 mg maintenance basis. It is a flat structure: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.

There is no membership line. $199 is the billed total — consultation and clinical review are inside it, and no platform fee recurs beside it, which removes the most common way advertised GLP-1 prices understate billed ones.

To place the number: #12 of 20 verified programs, with the floor $66/month below at Oak Longevity ($133); the approved-product yardstick (Wegovy (NovoCare↗)) sits at $349, so the compounded case here is worth $150 a month. A year at this figure: $2,388 monthly-billed.

Semaglutide, across time

The same $199 figure, stretched across the horizons people actually budget for:

1 month: $199 billed monthly. 3 months: $597 billed monthly; no prepaid term is published at this horizon, so monthly billing is the only path. 6 months: $1,194 billed monthly; no prepaid term is published at this horizon, so monthly billing is the only path. 9 months: $1,791 billed monthly; no prepaid term is published at this horizon, so monthly billing is the only path. 12 months: $2,388 billed monthly; no prepaid term is published at this horizon, so monthly billing is the only path. 18 months: $3,582 billed monthly; no prepaid term is published at this horizon, so monthly billing is the only path. 24 months: $4,776 billed monthly; no prepaid term is published at this horizon, so monthly billing is the only path.

Remember what the arithmetic cannot know: whether you will tolerate the medication, whether the dose will move (financially irrelevant here, since pricing is flat), and whether the program’s terms will hold. The calculator reruns all of this at your inputs.

Where this price sits — semaglutide

In the semaglutide index, Noom Med ranks #12 of 20 verified programs — $66 a month above the floor (Oak Longevity, $133) and $149 under the ceiling (LifeMD↗, $348). One rung cheaper sits SkinnyRx↗ at $199 — a $0 monthly gap, $0 across a year — the head-to-head is at Noom Med vs SkinnyRx. One rung pricier is ShedRx↗ at $249 (+$50/month); that comparison lives at Noom Med vs ShedRx. Against the approved product: Wegovy (NovoCare) runs $349 at maintenance, so Noom Med is $150 a month ($1,800/year) under brand; note the $199 rate is a two-month introductory price at starter doses.

Against the five nearest rivals — semaglutide

SkinnyRx is priced identically at $199 (no membership, dose-flat). Eden costs $1 less a month ($12/year) at $198 ($99/mo membership inside its figure, dose-flat). Henry Meds costs $20 less a month ($240/year) at $179 (no membership, dose-flat). Mochi Health costs $21 less a month ($252/year) at $178 ($79/mo membership inside its figure, dose-flat). Fridays costs $24 less a month ($288/year) at $175 (no membership, dose-flat).

Operationally: Shipping is included, so the door-to-door figure is the advertised figure; the clinical consultation is included rather than billed separately; labs are not required to enroll (a prescriber can still order them for cause, which is medicine, not upsell); the visit model is async. Commitment: 12-week cycles; cancellation: 12-week billing cycles. Fulfillment is unusually checkable: Noom Med names its pharmacy network — Tailor Made Compounding (named) (named 503A/503B partner) — which means a careful reader can verify licenses with state boards and, for 503B facilities, the FDA’s registration list. Most of this market refuses that test.

Where these numbers come from: source-verified, last read 2026-08-08 from the provider’s published pages, archived at capture. Every figure above traces to a dated capture; when the provider’s page changes, the database changes, and the diff lands in the changelog. If any number here no longer matches what Noom Med publishes, tell the desk — confirmed errors are fixed sitewide in one rebuild and logged permanently.

§ Adjacent pages